Personalized medicine for patients with COPD: where are we?

Chronic airflow limitation is the common denominator of patients with chronic obstructive pulmonary disease (COPD). However, it is not possible to predict morbidity and mortality of individual patients based on the degree of lung function impairment, nor does the degree of airflow limitation allow g...

Descripción completa

Detalles Bibliográficos
Autores principales: Franssen, Frits ME, Alter, Peter, Bar, Nadav, Benedikter, Birke J, Iurato, Stella, Maier, Dieter, Maxheim, Michael, Roessler, Fabienne K, Spruit, Martijn A, Vogelmeier, Claus F, Wouters, Emiel FM, Schmeck, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636434/
https://www.ncbi.nlm.nih.gov/pubmed/31371934
http://dx.doi.org/10.2147/COPD.S175706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636434/
https://www.ncbi.nlm.nih.gov/pubmed/31371934
http://dx.doi.org/10.2147/COPD.S175706

Ejemplares similares